Compare · CERS vs WST

CERS vs WST

Side-by-side comparison of Cerus Corporation (CERS) and West Pharmaceutical Services Inc. (WST): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CERS and WST operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • WST is the larger of the two at $29.10B, about 77.7x CERS ($374.7M).
  • Over the past year, CERS is up 21.6% and WST is up 59.0% - WST leads by 37.5 points.
  • CERS has been more active in the news (7 items in the past 4 weeks vs 6 for WST).
  • WST has more recent analyst coverage (20 ratings vs 4 for CERS).
PerformanceCERS+24.41%WST+59.04%
2025-11-18+0.00%2026-11-17
MetricCERSWST
Company
Cerus Corporation
West Pharmaceutical Services Inc.
Price
-
-
Market cap
$374.7M
$29.10B
1M return
-16.40%
+8.80%
1Y return
+21.57%
+59.04%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NYSE
IPO
1997
News (4w)
7
6
Recent ratings
4
20
CERS

Cerus Corporation

Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation has collaboration with LifeSouth Community Blood Centers to manufacture INTERCEPT Fibrinogen Complex. The company was incorporated in 1991 and is headquartered in Concord, California.

WST

West Pharmaceutical Services Inc.

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Latest CERS

Latest WST